Cancer Treatment Patent Using Quinoline Derivative and Antibody

Sat, 11 Apr 2026 15:29:17 +0000
Intellectual Property

The USPTO published patent application US20260097030A1 on April 9, 2026, disclosing a therapeutic combination of a quinoline derivative and an antibody for treating cancer, specifically lung and liver tumors. The application names 14 inventors and was filed on April 11, 2025. This publication makes the application publicly available but does not grant any enforceable patent rights.